Sanofi and IGM Biosciences team up to develop antibody agonists
Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval
Read More
Tag: IMG Biosciences
- Strong clinical data for Breye lead asset danegaptide
- EHP Awards triumph
- Kahimmune Therapeutics enters licensing agreement with Gustave Roussy and SATT Paris-Saclay
- IBSA UK&I launches Perovial for the treatment of acute Peyronie’s disease
- En Carta Diagnostics’ EC Pocket Lyme test receives FDA Breakthrough Device Designation
